<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id><journal-id journal-id-type="publisher-id">vaccines</journal-id><journal-title-group><journal-title>Vaccines</journal-title></journal-title-group><issn pub-type="epub">2076-393X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006750</article-id><article-id pub-id-type="pmc">PMC11860572</article-id><article-id pub-id-type="doi">10.3390/vaccines13020204</article-id><article-id pub-id-type="publisher-id">vaccines-13-00204</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Multivalent Inactivated Vaccine Protects Chickens from Distinct Clades of Highly Pathogenic Avian Influenza Subtypes H5N1 and H5N8</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/https://orcid.org/0000-0002-4242-507X</contrib-id><name><surname>Kilany</surname><given-names>Walid H.</given-names></name><xref rid="af1-vaccines-13-00204" ref-type="aff">1</xref><xref rid="af2-vaccines-13-00204" ref-type="aff">2</xref><xref rid="c1-vaccines-13-00204" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Safwat</surname><given-names>Marwa</given-names></name><xref rid="af1-vaccines-13-00204" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/https://orcid.org/0000-0001-7336-7733</contrib-id><name><surname>Zain El-Abideen</surname><given-names>Mohamed A.</given-names></name><xref rid="af1-vaccines-13-00204" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6480-5591</contrib-id><name><surname>Hisham</surname><given-names>Islam</given-names></name><xref rid="af1-vaccines-13-00204" ref-type="aff">1</xref><xref rid="af2-vaccines-13-00204" ref-type="aff">2</xref><xref rid="c1-vaccines-13-00204" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Moussa</surname><given-names>Yasmine</given-names></name><xref rid="af2-vaccines-13-00204" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2576-2031</contrib-id><name><surname>Ali</surname><given-names>Ahmed</given-names></name><xref rid="af3-vaccines-13-00204" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Elkady</surname><given-names>Magdy F.</given-names></name><xref rid="af3-vaccines-13-00204" ref-type="aff">3</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Takimoto</surname><given-names>Toru</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vaccines-13-00204"><label>1</label>Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), P.O. Box 264, Dokki, Giza 12618, Egypt; <email>marwasafwat13@yahoo.com</email> (M.S.); <email>zien_vet@yahoo.com</email> (M.A.Z.E.-A.)</aff><aff id="af2-vaccines-13-00204"><label>2</label>MEVAC&#x02014;Middle East for Vaccines, Second Industrial Area, El-Salhya El-Gededa 44813, Egypt; <email>y.mousa@me-vac.com</email></aff><aff id="af3-vaccines-13-00204"><label>3</label>Poultry Diseases Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62511, Egypt; <email>ahmed.ali1@vet.bsu.edu.eg</email> (A.A.); <email>mfelkady@vet.bsu.edu.eg</email> (M.F.E.)</aff><author-notes><corresp id="c1-vaccines-13-00204"><label>*</label>Correspondence: <email>walidhamdy78@yahoo.com</email> (W.H.K.); <email>islamhisham@vetmed.dmu.edu.eg</email> (I.H.)</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>204</elocation-id><history><date date-type="received"><day>17</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>14</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>15</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background/Objective: Highly pathogenic avian influenza (HPAI) H5 subtype remains a significant menace to both the poultry industry and human public health. Biosecurity and mass vaccination of susceptible commercial poultry flocks are crucial to reduce the devastating economic loss and hinder the evolution of the virus. Methods: In this study, we developed a multivalent avian influenza virus (AIV) vaccine, including strains representing the HPAI 2.2.1.1., 2.2.1.2., and 2.3.4.4b clades circulating in Egypt and the Middle East. Specific pathogen-free (SPF) two-week-old chickens were vaccinated with a single vaccine shot and observed for four weeks post-vaccination before being challenged. The challenge experiment involved using one strain of HPAI H5N1 subtype clade 2.2.1.2 and two strains of HPAI H5N8 subtype clade 2.3.4.4b derived from chickens and ducks. To assess the vaccine&#x02019;s potency and efficacy, the pre-challenge humoral immune response and post-challenge survival and virus shedding were evaluated. <bold>Results:</bold> All the vaccinated birds exhibited 100% seroconversion 2 weeks post-vaccination (2 WPV). In addition, protective antibody titers against each diagnostic antigen, i.e., 7.8 &#x000b1; 1.8 (H5N1, clade 2.2.1.2), 10.0 &#x000b1; 0.0 (H5N1, clade 2.2.1.1), and 7.5 &#x000b1; 0.9 (H5N8, clade 2.3.4.4b) were detected 3 WPV. The vaccination achieved complete protection (100%) against all challenge viruses with no disease symptoms. The vaccinated birds exhibited a statistically significant reduction in oropharyngeal virus shedding 2 days post-challenge (DPC). Conclusions: This study illustrated that a single application of a multivalent genetic-matching whole AIV vaccine under laboratory conditions elicits adequate protection against the HPAI challenge, representing 2.2.1.2 and 2.3.4.4b clades. The developed vaccine has the potential to be a vaccine of choice against a broad range of HPAI in commercial flocks raised under field conditions in endemic areas.</p></abstract><kwd-group><kwd>avian influenza</kwd><kwd>highly pathogenic avian influenza virus</kwd><kwd>chicken</kwd><kwd>H5N1</kwd><kwd>H5N8</kwd><kwd>HPAI</kwd><kwd>vaccine</kwd></kwd-group><funding-group><award-group><funding-source>Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute (AHRI)</funding-source></award-group><award-group><funding-source>MEVAC&#x02014;Middle East for Vaccines, Egypt</funding-source></award-group><funding-statement>This research was supported by the Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute (AHRI), Dokki, Giza 12618, Egypt, and MEVAC&#x02014;Middle East for Vaccines, Egypt.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vaccines-13-00204"><title>1. Introduction</title><p>The goose/Guangdong (gs/GD) lineage of avian influenza H5 viruses has undergone consistent genetic and antigenic changes, resulting in the formation of several clades since 1996. These clades exhibit different levels of pathogenicity for avian hosts [<xref rid="B1-vaccines-13-00204" ref-type="bibr">1</xref>]. Avian influenza viruses (AIVs) are named after their main surface proteins, i.e., hemagglutinin (HA) and neuraminidase (NA). Of the 18 HA and 11 NA subtypes identified, 16 HA and 9 NA subtypes have been found in birds [<xref rid="B2-vaccines-13-00204" ref-type="bibr">2</xref>]. Based on their ability to cause disease in chickens, avian influenza viruses are classified as low pathogenicity (LPAI) or highly pathogenic (HPAI).</p><p>HPAI H5N1 used to be the most common subtype of the Gs/GD lineage. However, in 2008, new NA subtypes of Gs/GD lineage HPAIVs belonging to the third order clade 2.3.4 were discovered in China. Later on, the HA underwent further diversification, resulting in the emergence of other subgroups categorized under the fourth order, i.e., clade 2.3.4.4 [<xref rid="B3-vaccines-13-00204" ref-type="bibr">3</xref>]. The exchange and reassortment of gene segments with LPAI viruses in domestic ducks and wild birds have evolved the viruses under clade 2.3.4.4 H5Nx into eight distinct fifth order HA genetic subgroups (a&#x02013;h) and numerous genotypes [<xref rid="B4-vaccines-13-00204" ref-type="bibr">4</xref>]. The ancestral strain of the HPAIV H5N8 subtype was obtained from ducks in China in 2010 and classified as clade 2.3.4.4. Over time, the strains have developed into clade 2.3.4.4a (resembling the Buan/Donglim strain) and 2.3.4.4b, which was initially identified in Korean birds (resembling the Gochang strain) [<xref rid="B5-vaccines-13-00204" ref-type="bibr">5</xref>].</p><p>Wild and domestic waterfowl have served as the natural host and primary reservoir of influenza A viruses [<xref rid="B6-vaccines-13-00204" ref-type="bibr">6</xref>,<xref rid="B7-vaccines-13-00204" ref-type="bibr">7</xref>]. Infected ducks often did not show disease symptoms; meanwhile, chickens exposed to HPAI viruses exhibited severe clinical signs and high mortality rates [<xref rid="B8-vaccines-13-00204" ref-type="bibr">8</xref>]. Widespread infections, impairment of the nervous system, and notable mortality in ducks were linked to HPAI H5N1viruses that emerged in Asia between 2002 and 2005 [<xref rid="B9-vaccines-13-00204" ref-type="bibr">9</xref>,<xref rid="B10-vaccines-13-00204" ref-type="bibr">10</xref>]. Consistently, HPAI H5N8 viruses that emerged in Asia have spread from ducks to infect other poultry species, e.g., chickens and turkeys [<xref rid="B11-vaccines-13-00204" ref-type="bibr">11</xref>,<xref rid="B12-vaccines-13-00204" ref-type="bibr">12</xref>]. Mallard ducks were linked to the genetic reassortment of HPAI viruses by the evolution of genetically distinct strains [<xref rid="B13-vaccines-13-00204" ref-type="bibr">13</xref>]. Several variables may contribute to the disease course and the immunological response of domestic chickens and ducks to HPAI viruses [<xref rid="B11-vaccines-13-00204" ref-type="bibr">11</xref>,<xref rid="B14-vaccines-13-00204" ref-type="bibr">14</xref>].</p><p>HPAI vaccination is a contentious issue in terms of its effectiveness as a means of prevention and control. Some experts have suggested that mismatched vaccination could contribute to an increase in HPAI cases in poultry and possibly contribute to the emergence of a pandemic in humans due to immune pressure [<xref rid="B15-vaccines-13-00204" ref-type="bibr">15</xref>]. Many, however, view vaccination as a crucial tool for effectively controlling HPAI and providing long-term health benefits to birds and humans [<xref rid="B16-vaccines-13-00204" ref-type="bibr">16</xref>]. Several AIV vaccines have been developed, including inactivated whole viral vaccines, recombinant virus vector vaccines, subunit vaccines, and DNA vaccines [<xref rid="B17-vaccines-13-00204" ref-type="bibr">17</xref>,<xref rid="B18-vaccines-13-00204" ref-type="bibr">18</xref>]. Conventional whole viral vaccines based on naturally occurring or genetically modified LPAI seeds represent the majority of the authorized AIV vaccines globally. To provide protection against a field virus, the vaccine seed should be epidemiologically relevant or closely linked genetically or antigenically [<xref rid="B17-vaccines-13-00204" ref-type="bibr">17</xref>,<xref rid="B19-vaccines-13-00204" ref-type="bibr">19</xref>]. Several reports have addressed the added value of multivalent vaccines for offering robust protection against HPAI viruses [<xref rid="B20-vaccines-13-00204" ref-type="bibr">20</xref>,<xref rid="B21-vaccines-13-00204" ref-type="bibr">21</xref>,<xref rid="B22-vaccines-13-00204" ref-type="bibr">22</xref>].</p><p>AIV vaccines can be evaluated either by a direct approach, via assessment of clinical protection against clinical signs and mortality, or by reducing the number of challenges of virus shedding through an experimental model [<xref rid="B23-vaccines-13-00204" ref-type="bibr">23</xref>]. In parallel, the indirect approach for AIV vaccine evaluation includes assessing the induced humoral immune response by serological testing, e.g., HI or ELISA [<xref rid="B2-vaccines-13-00204" ref-type="bibr">2</xref>]. Antibody titers have a positive predictive value in determining the effectiveness of vaccines in protecting against a challenge from HPAI strains [<xref rid="B24-vaccines-13-00204" ref-type="bibr">24</xref>]. The World Organization of Animal Health (WOAH) Terrestrial Manual stated that the minimum post-vaccinal serological titers using HI test should be at least 5 log<sub>2</sub> and 7 log<sub>2</sub> in order to protect from mortality or decrease the challenge of virus replication and shedding, respectively. Furthermore, a standardized vaccine efficacy evaluation scheme includes at least an 80% survival rate against challenge with a representative HPAI strain able to induce 90% mortality in the sham population [<xref rid="B18-vaccines-13-00204" ref-type="bibr">18</xref>].</p><p>This study aimed to assess the effectiveness of a whole inactivated multivalent virus vaccine against the HPAI viruses representing distinct clades. The vaccine contained AIVs representing clades 2.2.1.1 (H5N1), 2.2.1.2 (H5N1), and 2.3.4.4b (H5N8). The evaluation approach included post-vaccinal serological monitoring, clinical protection, and the reduction in the shedding titers after exposure to challenge viruses derived from different poultry species.</p></sec><sec id="sec2-vaccines-13-00204"><title>2. Materials and Methods</title><sec id="sec2dot1-vaccines-13-00204"><title>2.1. Viruses</title><p>Reassortant AIV H5N1 (A/chicken/Eg/RG-173CAL/2017) and (RgA/chicken/Egypt/ME1010/2016) belonging to clades 2.2.1.2 (acc. no. MG192005.1) and 2.2.1.1. (acc. no. MH558951.1), respectively, were developed previously by the Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute (AHRI), Egypt [<xref rid="B19-vaccines-13-00204" ref-type="bibr">19</xref>]. Reassortant AIV H5N8 (rgA/chicken/ME-2018/H5N8) belonging to clade 2.3.4.4b (acc. no. MW193074.1) was developed by MEVAC&#x02014;Middle East for Vaccines, Giza, Egypt [<xref rid="B20-vaccines-13-00204" ref-type="bibr">20</xref>].</p><p>HPAI challenge viruses A/chicken/EG/1575S (H5N1 clade 2.2.1.2., EPI_ISL_174424), A/chicken/Egypt/A4/2021 (H5N8 clade 2.3.4.4b, acc. no. ON024718), A/duck/Egypt/FAOSL4/2021 (H5N8 clade 2.3.4.4b, acc. no. ON024724) were provided by RLQP, Giza, Egypt and selected to estimate the vaccine efficacy in the experimental model. All the viruses were propagated and titrated using 10-day-old specific pathogen-free (SPF) embryonated chicken eggs (ECE) obtained from Nile SPF eggs, Kom Oshiem, Fayoum, Egypt. Virus titration was performed by inoculating ten-fold serial dilutions of the virus samples into the allantoic sacs of SPF ECE, as previously described [<xref rid="B25-vaccines-13-00204" ref-type="bibr">25</xref>].</p></sec><sec id="sec2dot2-vaccines-13-00204"><title>2.2. HA Gene Sequence Analysis</title><p>Available sequences of AIV H5Nx isolated from avian species were retrieved from the GISAID Data Science Initiative&#x02014;EpiFlu&#x02122; database (GISAID <ext-link xlink:href="https://gisaid.org/" ext-link-type="uri">https://gisaid.org/</ext-link>; Munich, Germany). Sequences were filtered down using the following criteria: Hemagglutinin H5 subtype, reported in Egypt (H5N8 subtype clade 2.3.4.4b, H5N1 subtype clades 2.2.1.1 and 2.2.1.2), and complete segments for HA, and years between 2016 and 2021. This approach resulted in 171 strains (clade 2.3.4.4b), 77 strains (clade 2.2.1.1), and 298 strains (clade 2.2.1.2). The HPAI strains were compared to the vaccine viruses. Deduced amino acid sequences were determined using Geneious<sup>&#x000ae;</sup> 7.1.3 (Biomatters Ltd., Auckland, New Zealand).</p></sec><sec id="sec2dot3-vaccines-13-00204"><title>2.3. Virus Inactivation and Vaccine Formulation</title><p>The virus harvests were inactivated using 0.2% formalin (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) (Merck KGaA, Darmstadt, Germany). The hemagglutination activity of the inactivated virus harvests was calculated using the hemagglutination test [<xref rid="B18-vaccines-13-00204" ref-type="bibr">18</xref>]. Inactivation completion was evaluated by inoculating three successive passages into 10-day-old SPF-ECE via the allantoic route. The antigen bulks were then mixed with MEVAC&#x02122; IMA 70 adjuvant (MEVAC, El-Salhya El-Gededa, Egypt) composed of liquid paraffin, Polysorbate 80, and Sorbitan oleate. The antigen aqueous phase was pre-emulsified with the oil adjuvant at a 30:70 ratio (<italic toggle="yes">w</italic>/<italic toggle="yes">w</italic>) at 1000 rpm using the Silverson<sup>&#x000ae;</sup> L5M high-shear laboratory mixer (Silverson Machines, Inc., Buckinghamshire, UK). The speed of the mixer was then increased to 3000 rpm and maintained for 30 min for the emulsification of 10,000 doses of the vaccine. The temperature of the mixture was kept between 18 and 22 &#x000b0;C during the emulsion formulation process. The formulated product was given the name MEFLUVAC&#x02122; H5 Plus 8 (MEVAC, El-Salhya El-Gededa, Egypt). Before being employed in animal trials, the produced emulsion was examined for its physicochemical properties, bacterial and fungal sterility [<xref rid="B26-vaccines-13-00204" ref-type="bibr">26</xref>], and freedom from mycoplasma [<xref rid="B27-vaccines-13-00204" ref-type="bibr">27</xref>].</p></sec><sec id="sec2dot4-vaccines-13-00204"><title>2.4. Evaluation of the Vaccine&#x02019;s Physicochemical Properties</title><p>The conductivity of the vaccine was measured by JENWAY<sup>&#x000ae;</sup> Model 4520 conductivity meter (Cole-Parmer<sup>&#x000ae;</sup>, Villepinte, France), while the vaccine&#x02019;s viscosity was estimated by Brookfield viscometer (AMETEK<sup>&#x000ae;</sup> Brookfield, PA, USA). The vaccine samples were centrifuged at 6000 rpm for 15 min using a CYAN Tabletop centrifuge (Cypress Diagnostics, Hulshout, Belgium) to determine the emulsion stability. The pH of the vaccine was measured using the JENWAY<sup>&#x000ae;</sup> Model 3510 Standard Digital pH Meter (Cole-Parmer<sup>&#x000ae;</sup>, Villepinte, France).</p></sec><sec id="sec2dot5-vaccines-13-00204"><title>2.5. Birds and Experimental Design</title><p>One hundred five (<italic toggle="yes">n</italic> = 105) SPF chickens, 2 weeks of age (2 WOA) (Nile SPF eggs, Kom Oshiem, Fayoum, Egypt), were allocated to the study. Forty-five birds (Group A, GA) were vaccinated with MEFLUVAC&#x02122; H5 Plus 8 vaccine (0.5 mL/bird) via intramuscular injection in the thigh muscles; however, the remaining sixty birds (Group B, GB) were inoculated with an equal volume of normal saline instead. Birds were reared separately in chicken isolators at the BSL-3 Laboratory Animal Facility, Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute (AHRI), Egypt. Feed and water were available ad libitum. Sera were collected from sixteen birds from each group on a weekly basis for 4 weeks post-vaccination (4 WPV).</p></sec><sec id="sec2dot6-vaccines-13-00204"><title>2.6. Measurement of Antibody Response</title><p>The hemagglutination inhibition (HI) test was carried out according to the WOAH manual [<xref rid="B18-vaccines-13-00204" ref-type="bibr">18</xref>] to monitor the post-vaccination humoral immune response using the diagnostic antigens representing AIV H5N1 subtype clades 2.2.1.1, 2.2.1.2, and AIV H5N8 subtype clade 2.3.4.4b viruses. Briefly, twofold serial dilutions of sera were mixed with four hemagglutination units of the diagnostic antigen. The HI titer was determined using a 1% red blood cell (RBC) suspension collected from at least three SPF chickens at least 8 weeks of age. Arithmetic means of HI titers were expressed as reciprocal log<sub>2,</sub> and inhibition of hemagglutination at a dilution &#x02265;2 log<sub>2</sub> was considered a specific antibody positive to AIV. The seroconversion rates were estimated as the proportion of birds with positive HI titers and were calculated using the following formula [<xref rid="B28-vaccines-13-00204" ref-type="bibr">28</xref>]:
<disp-formula id="FD1-vaccines-13-00204"><label>(1)</label><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">w</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">H</mml:mi><mml:mi mathvariant="normal">I</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo>(</mml:mo><mml:mo>&#x02265;</mml:mo><mml:mn>3.0</mml:mn><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec2dot7-vaccines-13-00204"><title>2.7. Challenge Experiment</title><p>At 6 weeks of age, the experimental birds of GA and GB were randomly divided into seven groups (<italic toggle="yes">n</italic> = 15 chicks/group) before conducting the challenge experiment. The vaccinated GA1 and the unvaccinated GB1 were challenged with HPAI virus resembling H5N1 subtype clades 2.2.1.2. Similarly, vaccinated GA2 and the unvaccinated GB2 were challenged with HPAI virus H5N8 subtype clade 2.3.4.4b (chicken origin, CO); meanwhile, vaccinated GA3 and the unvaccinated GB3 were challenged with HPAI virus H5N8 subtype clade 2.3.4.4b (duck origin, DO). Each challenged bird received 100 &#x003bc;L containing 6.0 log<sub>10</sub> EID<sub>50</sub> from the particular HPAI viruses via the oculonasal route using a calibrated micropipette. Birds allotted to GB4 were inoculated with an equal volume of normal saline and then kept as a negative control (NC) sham. Chickens were monitored for 10 days post-challenge (10 DPC) for clinical signs and mortality, and the observations were recorded daily until the end of each trial (<xref rid="vaccines-13-00204-t001" ref-type="table">Table 1</xref> and <xref rid="vaccines-13-00204-f001" ref-type="fig">Figure 1</xref>). The mean death time (MDT) was calculated as the average death time at 24 h intervals for each challenge strain utilized in GB1-GB3 [<xref rid="B29-vaccines-13-00204" ref-type="bibr">29</xref>].</p></sec><sec id="sec2dot8-vaccines-13-00204"><title>2.8. Viral Re-Isolation and Detection</title><p>Oropharyngeal (OP) swabs were sampled 2, 4, 7, and 10 DPC. Samples were collected in a 1 mL phosphate-buffered saline, pH 7.2, containing gentamycin (50 &#x003bc;g/mL) and nystatin (1000 U/mL) (20). Swab samples were vortexed and then centrifuged at 2000 rpm for 10 min. at 4 &#x000b0;C to pellet the debris. The supernatants of individual samples were tested via virus titration to monitor virus shedding in 10-day-old SPF ECE. The infective dose (EID<sub>50</sub>/mL) was then calculated [<xref rid="B30-vaccines-13-00204" ref-type="bibr">30</xref>].</p></sec><sec id="sec2dot9-vaccines-13-00204"><title>2.9. Ethics Statement</title><p>The challenge experiment was carried out inside BSL-3 chicken isolators at the Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Egypt. The study was designed to minimize animal suffering and was conducted in conformity with the provisions related to ARRIVE Guidelines 2.0 [<xref rid="B31-vaccines-13-00204" ref-type="bibr">31</xref>]. All the experimental procedures were reviewed and approved by the Animal Care and Use Committee (ACUC) (no. RLQP-VP20-2107).</p></sec><sec id="sec2dot10-vaccines-13-00204"><title>2.10. Statistical Analysis</title><p>The variations in titer shedding between groups were analyzed using one-way ANOVA with Tukey&#x02019;s post-test, as appropriate, using GraphPad Prism version 7.00 for Windows (GraphPad Software, San Diego, CA, USA, <uri xlink:href="www.graphpad.com">www.graphpad.com</uri>). A <italic toggle="yes">p</italic>-value &#x0003c; 0.05 was considered statistically significant. Descriptive statistics was used to describe the results of the physicochemical properties of the investigated product as well as the antibody titers of the tested vaccine groups using Microsoft<sup>&#x000ae;</sup> Excel software, Microsoft<sup>&#x000ae;</sup> Corporation, Redmond, WA, USA. A Kaplan&#x02013;Meir curve was used to illustrate the cumulative survival of the experimental groups during the observation period.</p></sec></sec><sec sec-type="results" id="sec3-vaccines-13-00204"><title>3. Results</title><sec id="sec3dot1-vaccines-13-00204"><title>3.1. Sequence Analysis of the AIV Strains</title><p>In general, the vaccine strains demonstrated a high amino acid percentage of identity, with their HPAI strains representing their counterpart clades. The reassortant LPAI H5N8 subtype vaccine strain, belonging to clade 2.3.4.4b, had an amino acid sequence identity range of 97&#x02013;100% with the HPAI H5N8 subtype clade 2.3.4.4b strains isolated from avian species in Egypt. The reassortant LPAI H5N1 subtype clade 2.2.1.2 and 2.2.1.1 vaccine strains exhibited an identity range of 94.6&#x02013;98.6% and 93.2&#x02013;96.3% with their analogous clades, respectively (<xref rid="vaccines-13-00204-t002" ref-type="table">Table 2</xref>).</p><p>The sequenced HA proteins of the HPAI challenge viruses in this investigation included multiple basic amino acids at their cleavage sites (KRRKKR/GLF for the HPAI H5N1 subtype and KRRK-R/GLF for the H5N8 subtype). Nevertheless, the reassortant vaccine strains exhibited a monobasic cleavage site, indicating the LPAI criteria. The amino acid residues H103, E186, G221, Q222, and G224 (H5 numbering) of all the studied strains indicated specificity towards &#x003b1;-2,3-linked sialic acid receptors present in the intestinal and respiratory tracts of birds (<xref rid="vaccines-13-00204-t003" ref-type="table">Table 3</xref>).</p><p>Chicken-originated HPAI H5N8 subtype clade 2.3.4.4b had the amino acid S129 linked to epitope A (eA), whereas duck-originated HPAI and the LPAI H5N8 strains of the same clade had the amino acid L129. However, a deletion in site 129 was consistently noticed in the examined AIV H5N1 clade 2.2.1.2 strains. Q115L and D124N associated with antigenic site (AS) and epitope A (eA) were observed in the AIV H5N8 subtype strains compared to H5N1 clade 2.2.1.2. Epitope B (eB) V174I, P181S, and R189N sites were consistently noticed in AIV H5N8 strains. Amino acids anticipated to correlate with epitope C (eC) were identical across all examined strains. Reassortant LPAI H5N1 subtype clade 2.2.1.1 vaccine strain showed T151I, A185E, and Q192K representing epitope D (eD) compared to the rest of the investigated strains. Amino acids predicted to be associated with epitope E (eE) exhibited complete identity among all the AIV H5N8 strains. Amino acid substitutions N43D, L71I, N72R, K82R, and I83A were observed in AIV H5N8 clade 2.3.4.4b strains compared to H5N1 clade 2.2.1.2; meanwhile, AIV H5N1 clade 2.2.1.1 strain demonstrated 71P and 83T (<xref rid="vaccines-13-00204-t003" ref-type="table">Table 3</xref>).</p><p>The receptor binding sites (RBSs) of the HA protein showed N94S in all the AIV H5N8 strains. All the RBSs exhibited complete identity between AIV H5N1 subtype 2.2.1.2 clade studied strains. AIV H5N8 subtype strains of different clades possessed S133A, D183N, and S223R. N-glycosylation sites were consistently detected. The analysis of the established sequences revealed the presence of six N-linked glycosylation sites at positions 11, 23, 165, 286, 483, and 542 (<xref rid="vaccines-13-00204-t003" ref-type="table">Table 3</xref>).</p></sec><sec id="sec3dot2-vaccines-13-00204"><title>3.2. Vaccine&#x02019;s Physicochemical Properties</title><p>No critical deviations from the predetermined acceptance limits of the physicochemical properties of the tested final container samples (<italic toggle="yes">n</italic> = 5) of the product were detected. The prepared water-in-oil (W/O) emulsion was proven homogenous and stable. The average conductivity, viscosity, and pH values were 0.001 &#x000b1; 0.003 &#x000b5;S/cm, 54.4 &#x000b1; 0.5 mPa.s, and 6.32 &#x000b1; 0.07, respectively. Also, the inspected samples were proven sterile without any detectable contaminating micro-organisms, i.e., bacteria, fungi, or mycoplasma, under the conditions of the tests.</p></sec><sec id="sec3dot3-vaccines-13-00204"><title>3.3. Post-Vaccination Humoral Immune Response</title><p>Serological responses against diagnostic antigens representing AIV H5N1 subtype clades 2.2.1.1 and 2.2.1.2 and H5N8 subtype clade 2.3.4.4b were detected in all the vaccinated birds (<xref rid="vaccines-13-00204-f002" ref-type="fig">Figure 2</xref>). The H5N1 clade 2.2.1.2 antigen elicited an average log<sub>2</sub> titer of 3.6 &#x000b1; 1.1 log<sub>2</sub> HIU 1 WPV, with a seroconversion rate of 88% in the vaccinated GA. The average immune response significantly increased to 6.3 &#x000b1; 1.2 log<sub>2</sub> HIU, and all birds (100%) exhibited seroconversion 2 WPV. The trend persisted at 3 and 4 WPV, with average immune responses of 7.8 &#x000b1; 1.8 and 8.4 &#x000b1; 1.5 log<sub>2</sub> HIU, respectively, and a seroconversion rate of 100% (<xref rid="vaccines-13-00204-t004" ref-type="table">Table 4</xref>).</p><p>All the GA vaccinated birds (100%) showed seroconversion for the H5N1 clade 2.2.1.1 antigen 1 WPV with an average immune response of 7.1 &#x000b1; 0.8 log<sub>2</sub> HIU. The high response observed in the following weeks remained consistent, with a mean immune response of 10.0 &#x000b1; 0.0 log<sub>2</sub> HIU at 2, 3, and 4 WPV, indicating complete seroconversion (<xref rid="vaccines-13-00204-t004" ref-type="table">Table 4</xref>).</p><p>The H5N8 clade 2.3.4.4b antigen elicited a mean immune response of 2.0 &#x000b1; 0.9 log<sub>2</sub> HIU at 1 WPV, with only 13% of the vaccinated birds of GA demonstrating seroconversion. In contrast, the mean immune response markedly increased to 7.5 &#x000b1; 0.9 log<sub>2</sub> HIU 2 WPV, with a 100% seroconversion rate. The immune response was sustained at 3 and 4 WPV, with mean HI titer values of 7.5 &#x000b1; 0.9 and 9.8 &#x000b1; 0.5 log<sub>2</sub> HIU, respectively, and complete seroconversion rates. The unvaccinated control GB lacked any detectable HI titers, denoting the study&#x02019;s validity (<xref rid="vaccines-13-00204-t004" ref-type="table">Table 4</xref>).</p></sec><sec id="sec3dot4-vaccines-13-00204"><title>3.4. Challenge Experiment in SPF Chickens</title><p>The vaccinated challenged (VC) chickens of GA1-GA3 were clinically protected against the challenge viruses, while the unvaccinated challenged (UC) GB1-GB3 developed obvious clinical signs by 2&#x02013;3 DPC. Clinical signs comprised ruffled feathers, lethargy, and dyspnea. Only two to three birds in GA1-GA3 displayed ruffled feathers after challenge; however, all the birds recovered 5DPC. The unvaccinated sentinels in GB4 showed no detectable signs of disease (<xref rid="app1-vaccines-13-00204" ref-type="app">Supplementary Table S1</xref>). All the vaccinated birds survived the challenges; meanwhile, the challenged controls showed 100% mortality. Mortality percentage in unvaccinated GB1 challenged with HPAI H5N1 subtype clade 2.2.1.2 virus was 100% 3 DPC with an MDT of 2.8 (<xref rid="vaccines-13-00204-f003" ref-type="fig">Figure 3</xref>A). Unvaccinated GB2 challenged with HPAI H5N8 subtype clade 2.3.4.4b virus (chicken origin) demonstrated 100% mortality 4 DPC with an MDT of 3.0 (<xref rid="vaccines-13-00204-f003" ref-type="fig">Figure 3</xref>B). Interestingly, all the unvaccinated birds in GB3 challenged with HPAI H5N8 subtype clade 2.3.4.4b virus (duck origin) died at 6 DPC with an MDT of 4.6 (<xref rid="vaccines-13-00204-f003" ref-type="fig">Figure 3</xref>C).</p><p>All the VC GA1-GA3 excreted significantly low levels of HPAI viruses in OP swabs after the challenge with at least a &#x02212;2.0 log<sub>10</sub> difference compared to the analogous UC control GB1-GB3 (<xref rid="vaccines-13-00204-t005" ref-type="table">Table 5</xref>). Two DPC, six out of fifteen birds (40%) tested positive in GA1 challenged with HPAI H5N1 subtype clade 2.2.1.2. The mean value decreased to 2.5 &#x000b1; 0.36 log<sub>10</sub> EID<sub>50</sub>, with only 3 out of 15 birds (20%) testing positive 4 DPC. The mean value of shedding in GA2 challenged with HPAI H5N8 subtype clade 2.3.4.4b (chicken origin) was 3.5 &#x000b1; 0.26 log<sub>10</sub> EID<sub>50</sub>, and 5 out of 15 birds (33%) tested positive 2 DPC. The shedding titers dropped ~1.0 log<sub>10</sub> EID<sub>50</sub>, with 3 out of 15 birds (20%) testing positive 4 DPC. The lowest shedding titers and numbers of shedders were observed in GA3 challenged with HPAI H5N8 subtype clade 2.3.4.4b (duck origin). Four out of 15 birds (27%) tested positive 2 DPC, then decreased to 2.4 &#x000b1; 0.0 log<sub>10</sub> EID<sub>50</sub> with 2 out of 15 positive birds (13%) 4DPC. At 7 DPC and 10 DPC, all birds (100%) of the VC GA1-GA3 tested negative for shedding viruses. Nonetheless, OP sampling of GB1-GB3 was unfeasible as all the challenged birds had succumbed 4&#x02013;6 DPC (<xref rid="vaccines-13-00204-f003" ref-type="fig">Figure 3</xref>). All the NC &#x02018;sham&#x02019; birds (100%) in GB4 tested negative for virus detection at all the sampling points (<xref rid="vaccines-13-00204-t005" ref-type="table">Table 5</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-vaccines-13-00204"><title>4. Discussion</title><p>The HPAI viruses inflict significant economic harm on the poultry industry and raise public health concerns due to their potential for zoonotic transmission [<xref rid="B6-vaccines-13-00204" ref-type="bibr">6</xref>,<xref rid="B33-vaccines-13-00204" ref-type="bibr">33</xref>]. HPAI H5N1 viruses of clade 2.2.1.1 have been reported in Egypt since 2008; meanwhile, strains belonging to clade 2.2.1.2 were identified in 2012 [<xref rid="B34-vaccines-13-00204" ref-type="bibr">34</xref>]. Since 2014, HPAI H5N8 clade 2.3.4.4 emerged in South Korea and has affected a wide range of wild birds and commercial poultry in Asia, America, Africa, and Europe [<xref rid="B35-vaccines-13-00204" ref-type="bibr">35</xref>]. The virus was reported in Egypt for the first time in late 2016 in migratory birds during an active surveillance program [<xref rid="B36-vaccines-13-00204" ref-type="bibr">36</xref>]. The virus subsequently disseminated to terrestrial poultry populations, leading to enormous mortalities [<xref rid="B37-vaccines-13-00204" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-13-00204" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-13-00204" ref-type="bibr">39</xref>]. Although <italic toggle="yes">Galliformes</italic> (landfowl) and <italic toggle="yes">Anseriformes</italic> (waterfowl) are commonly afflicted by AIVs, even with diversified clinical patterns, the development, dissemination, and persistence of the HPAI H5N8 subtype have been associated with both domestic and wild aquatic birds [<xref rid="B5-vaccines-13-00204" ref-type="bibr">5</xref>]. The variation in pathogenicity between the two species can be ascribed to changes in their immune responses and susceptibility to the virus [<xref rid="B40-vaccines-13-00204" ref-type="bibr">40</xref>].</p><p>The primary strategies for curbing the spread of HPAIVs are stamping out, biosecurity measures, and immunization. In China, integration between the three strategies was considered crucial for controlling the spread of AIVs effectively [<xref rid="B41-vaccines-13-00204" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-13-00204" ref-type="bibr">42</xref>]. In Egypt, vaccination of susceptible commercial terrestrial poultry was prioritized due to the significant allocation of resources required for culling diseased birds or controlling live bird markets. Nevertheless, a national vaccination strategy was not executed in a manner comparable to the Chinese model [<xref rid="B43-vaccines-13-00204" ref-type="bibr">43</xref>]. Multiple reports have determined the beneficial impact of genetically matched AIV vaccines [<xref rid="B19-vaccines-13-00204" ref-type="bibr">19</xref>,<xref rid="B20-vaccines-13-00204" ref-type="bibr">20</xref>].</p><p>Comprehending the specific molecular factors that cause the gradual changes in the antigenic properties of HA glycoprotein is essential for developing vaccines against H5 avian influenza viruses [<xref rid="B44-vaccines-13-00204" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-13-00204" ref-type="bibr">45</xref>]. To provide comprehensive defense against AIVs, genetically matched vaccines should stimulate the production of antibodies that specifically target conserved viral epitopes, such as the RBS [<xref rid="B24-vaccines-13-00204" ref-type="bibr">24</xref>,<xref rid="B46-vaccines-13-00204" ref-type="bibr">46</xref>]. Multivalent vaccines utilized in endemic regions have demonstrated immunogenicity and robust protection against circulating HPAI viruses [<xref rid="B47-vaccines-13-00204" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-13-00204" ref-type="bibr">48</xref>].</p><p>In this study, a trivalent inactivated reassortant of whole AIV antigens representing three distinct clades, 2.2.1.1, 2.2.1.2, and 2.3.4.4b, combined with an oil adjuvant, was developed. The vaccine was designed to confer protection against a broad range of HPAI strains circulating in Egypt and the Middle East. An experimental model based on single-dose vaccine administration to SPF chickens was used to evaluate the vaccine. The vaccinated birds exhibited complete seroconversion as well as protective antibody levels, i.e., &#x02265;5 log<sub>2</sub> against each of the vaccine fractions were seen two weeks after vaccine application. Although the H5N8 vaccine fraction had the lowest seroconversion rate in the first week following vaccination, no interference was noticed in the subsequent weeks. These results are consistent with prior findings from the bivalent form of the vaccine [<xref rid="B20-vaccines-13-00204" ref-type="bibr">20</xref>]. The peak levels of antibodies were seen four weeks after immunization. The vaccine met the potency criteria outlined in the WOAH Terrestrial Manual [<xref rid="B18-vaccines-13-00204" ref-type="bibr">18</xref>].</p><p>Clinical signs, mortality, and oropharyngeal virus shedding are widely used to estimate the effectiveness of the vaccine against challenges [<xref rid="B43-vaccines-13-00204" ref-type="bibr">43</xref>,<xref rid="B49-vaccines-13-00204" ref-type="bibr">49</xref>]. HPAI H5-subtype challenge viruses representing clades 2.2.1.2 (H5N1) and 2.3.4.4b (H5N8) derived from chicken and duck origins were used for efficacy assessment of the vaccine. The vaccine induced 100% protection against the challenge viruses used. The pre-existing humoral antibody levels before the experimental challenge iterated the favorable correlation with optimal protection [<xref rid="B50-vaccines-13-00204" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-13-00204" ref-type="bibr">51</xref>]. The majority of the vaccinated birds showed no clinical signs associated with the HPAI challenges; meanwhile, the observed mild clinical signs were resolved by 5 DPC.</p><p>In contrast, the unvaccinated challenged birds showed severe clinical signs 1 DPC. HPAI H5N8 subtype clade 2.3.4.4b viruses were reported to be associated with lower pathogenicity in poultry species compared to HPAI H5N1 viruses [<xref rid="B52-vaccines-13-00204" ref-type="bibr">52</xref>]. It is worth noting that despite none of the unvaccinated controls having survived the experimental challenge, each of the HPAI strains resulted in different mortality patterns. The duck-originated HPAI H5N8 subtype challenge strain took six days, resulting in 100% mortality with the longest MDT, i.e., 4.6 days; however, four days were sufficient for the chicken-originated strain with an MDT of 3.0. HPAI H5N1 subtype clade 2.2.1.2 strain achieved 100% mortality by 3 DPC with an MDT of 2.8. Similar findings were attributed to the species from which the HPAI strains were isolated [<xref rid="B52-vaccines-13-00204" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-13-00204" ref-type="bibr">53</xref>]. A comparative pathogenicity evaluation of the challenge of HPAI viruses would provide a better understanding of virus pathobiology and transmission.</p><p>Vaccines are crucial in providing clinical protection, decreasing the amount of virus shedding, and providing enduring immunity against HPAI viruses [<xref rid="B54-vaccines-13-00204" ref-type="bibr">54</xref>]. Efficient implementation of an immunization strategy is crucial because of the zoonotic repercussions of HPAI outbreaks, highlighting the necessity for control measures [<xref rid="B55-vaccines-13-00204" ref-type="bibr">55</xref>]. The vaccinated groups had at least a twofold reduction in the overall number of birds shedding the virus compared to the unvaccinated groups 2 DPC. Consistently, no challenge viruses were found in the vaccinated groups 7 DPC. These findings adhere to the potency levels specified in WOAH. Quantitative PCR (qRT-PCR) is capable of sensitive detection and determining the amount of viral excretion; however, titration of oropharyngeal swabs in SPF ECE provided reliable information on the virus infectivity in the tested samples. Further evaluation of the multivalent vaccine in commercial birds will emphasize its potency and effectiveness under field conditions.</p></sec><sec sec-type="conclusions" id="sec5-vaccines-13-00204"><title>5. Conclusions</title><p>The developed multivalent vaccine was potent as determined by the post-vaccinal immune response and effective as indicated by clinical protection, survival rates, and reduced oropharyngeal virus shedding against challenge with HPAI H5 subtype representing clades 2.2.1.2 and 2.3.4.4b derived from chicken and duck origins. It is recommended that the combined vaccine be evaluated under field conditions with commercially raised birds, such as broilers or layers/breeders.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vaccines-13-00204"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/vaccines13020204/s1">https://www.mdpi.com/article/10.3390/vaccines13020204/s1</uri>. Supplementary Table S1. Monitoring experimental chickens during the observation period post-challenge.</p><supplementary-material id="vaccines-13-00204-s001" position="float" content-type="local-data"><media xlink:href="vaccines-13-00204-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization: W.H.K., M.S. and M.F.E.; data curation, I.H.; investigation, M.A.Z.E.-A., Y.M. and A.A.; methodology, W.H.K. and M.S.; resources, M.A.Z.E.-A. and Y.M.; software, I.H.; supervision, M.F.E.; writing&#x02014;original draft, I.H.; writing&#x02014;review and editing, W.H.K. and A.A. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The challenge experiment was carried out inside BSL-3 chicken isolators at Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Egypt. The study was conducted in conformity with the provisions related to ARRIVE Guidelines 2.0 [<xref rid="B31-vaccines-13-00204" ref-type="bibr">31</xref>]. All the experimental procedures were reviewed and approved by the Animal Care and Use Committee (ACUC) (no. RLQP-VP20-2107).</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are available in this article and the <xref rid="app1-vaccines-13-00204" ref-type="app">Supplementary Materials</xref>.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>Walid H. Kilany and I.H. disclose that they are affiliated with the Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Egypt, and MEVAC&#x02014;Middle East for Vaccines, Egypt. The research presented in this article was conducted in part through collaboration between these two entities. The authors declare no conflicts of interest could have influenced the work reported in this manuscript.</p></notes><ref-list><title>References</title><ref id="B1-vaccines-13-00204"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alkie</surname><given-names>T.N.</given-names></name>
<name><surname>Byrne</surname><given-names>A.M.</given-names></name>
<name><surname>Jones</surname><given-names>M.E.</given-names></name>
<name><surname>Mollett</surname><given-names>B.C.</given-names></name>
<name><surname>Bourque</surname><given-names>L.</given-names></name>
<name><surname>Lung</surname><given-names>O.</given-names></name>
<name><surname>James</surname><given-names>J.</given-names></name>
<name><surname>Yason</surname><given-names>C.</given-names></name>
<name><surname>Banyard</surname><given-names>A.C.</given-names></name>
<name><surname>Sullivan</surname><given-names>D.</given-names></name>
</person-group><article-title>Recurring Trans-Atlantic Incursion of Clade 2.3. 4.4 b H5N1 Viruses by Long Distance Migratory Birds from Northern Europe to Canada in 2022/2023</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>1836</elocation-id><pub-id pub-id-type="doi">10.3390/v15091836</pub-id><pub-id pub-id-type="pmid">37766243</pub-id>
</element-citation></ref><ref id="B2-vaccines-13-00204"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Swayne</surname><given-names>D.E.</given-names></name>
<name><surname>Suarez</surname><given-names>D.L.</given-names></name>
<name><surname>Sims</surname><given-names>L.D.</given-names></name>
</person-group><article-title>Influenza</article-title><source>Diseases of Poultry</source><publisher-name>Wiley</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2020</year><fpage>210</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1002/9781119371199.ch6</pub-id></element-citation></ref><ref id="B3-vaccines-13-00204"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>D.H.</given-names></name>
<name><surname>Bertran</surname><given-names>K.</given-names></name>
<name><surname>Kwon</surname><given-names>J.H.</given-names></name>
<name><surname>Swayne</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Evolution, global spread, and pathogenicity of highly pathogenic avian influenza H5Nx clade 2.3.4.4</article-title><source>J. Vet. Sci.</source><year>2017</year><volume>18</volume><fpage>269</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.4142/jvs.2017.18.S1.269</pub-id><pub-id pub-id-type="pmid">28859267</pub-id>
</element-citation></ref><ref id="B4-vaccines-13-00204"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kwon</surname><given-names>J.H.</given-names></name>
<name><surname>Bertran</surname><given-names>K.</given-names></name>
<name><surname>Lee</surname><given-names>D.H.</given-names></name>
<name><surname>Criado</surname><given-names>M.F.</given-names></name>
<name><surname>Killmaster</surname><given-names>L.</given-names></name>
<name><surname>Pantin-Jackwood</surname><given-names>M.J.</given-names></name>
<name><surname>Swayne</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Diverse infectivity, transmissibility, and pathobiology of clade 2.3.4.4 H5Nx highly pathogenic avian influenza viruses in chickens</article-title><source>Emerg. Microbes Infect.</source><year>2023</year><volume>12</volume><fpage>2218945</fpage><pub-id pub-id-type="doi">10.1080/22221751.2023.2218945</pub-id><pub-id pub-id-type="pmid">37309051</pub-id>
</element-citation></ref><ref id="B5-vaccines-13-00204"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grund</surname><given-names>C.</given-names></name>
<name><surname>Hoffmann</surname><given-names>D.</given-names></name>
<name><surname>Ulrich</surname><given-names>R.</given-names></name>
<name><surname>Naguib</surname><given-names>M.</given-names></name>
<name><surname>Schink&#x000f6;the</surname><given-names>J.</given-names></name>
<name><surname>Hoffmann</surname><given-names>B.</given-names></name>
<name><surname>Harder</surname><given-names>T.</given-names></name>
<name><surname>Saenger</surname><given-names>S.</given-names></name>
<name><surname>Zscheppang</surname><given-names>K.</given-names></name>
<name><surname>T&#x000f6;nnies</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>A novel European H5N8 influenza A virus has increased virulence in ducks but low zoonotic potential</article-title><source>Emerg. Microbes Infect.</source><year>2018</year><volume>7</volume><fpage>132</fpage><pub-id pub-id-type="doi">10.1038/s41426-018-0130-1</pub-id><pub-id pub-id-type="pmid">30026505</pub-id>
</element-citation></ref><ref id="B6-vaccines-13-00204"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Runstadler</surname><given-names>J.A.</given-names></name>
<name><surname>Puryear</surname><given-names>W.B.</given-names></name>
</person-group><article-title>The virus is out of the barn: The emergence of HPAI as a pathogen of avian and mammalian wildlife around the globe</article-title><source>Am. J. Vet. Res.</source><year>2024</year><volume>85</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.2460/ajvr.24.01.0018</pub-id><pub-id pub-id-type="pmid">39094616</pub-id>
</element-citation></ref><ref id="B7-vaccines-13-00204"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Webster</surname><given-names>R.G.</given-names></name>
<name><surname>Bean</surname><given-names>W.J.</given-names></name>
<name><surname>Gorman</surname><given-names>O.T.</given-names></name>
<name><surname>Chambers</surname><given-names>T.M.</given-names></name>
<name><surname>Kawaoka</surname><given-names>Y.</given-names></name>
</person-group><article-title>Evolution and ecology of influenza A viruses</article-title><source>Microbiol. Rev.</source><year>1992</year><volume>56</volume><fpage>152</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1128/mr.56.1.152-179.1992</pub-id><pub-id pub-id-type="pmid">1579108</pub-id>
</element-citation></ref><ref id="B8-vaccines-13-00204"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Su</surname><given-names>Q.</given-names></name>
<name><surname>Luo</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Wu</surname><given-names>Q.</given-names></name>
<name><surname>Chang</surname><given-names>H.</given-names></name>
<name><surname>Du</surname><given-names>J.</given-names></name>
<name><surname>Huang</surname><given-names>C.</given-names></name>
<name><surname>Ma</surname><given-names>J.</given-names></name>
<name><surname>Han</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Differences in Highly Pathogenic H5N6 Avian Influenza Viral Pathogenicity and Inflammatory Response in Chickens and Ducks</article-title><source>Front. Microbiol.</source><year>2021</year><volume>12</volume><elocation-id>593202</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.593202</pub-id><pub-id pub-id-type="pmid">33584608</pub-id>
</element-citation></ref><ref id="B9-vaccines-13-00204"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kishida</surname><given-names>N.</given-names></name>
<name><surname>Sakoda</surname><given-names>Y.</given-names></name>
<name><surname>Isoda</surname><given-names>N.</given-names></name>
<name><surname>Matsuda</surname><given-names>K.</given-names></name>
<name><surname>Eto</surname><given-names>M.</given-names></name>
<name><surname>Sunaga</surname><given-names>Y.</given-names></name>
<name><surname>Umemura</surname><given-names>T.</given-names></name>
<name><surname>Kida</surname><given-names>H.</given-names></name>
</person-group><article-title>Pathogenicity of H5 influenza viruses for ducks</article-title><source>Arch. Virol.</source><year>2005</year><volume>150</volume><fpage>1383</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.1007/s00705-004-0473-x</pub-id><pub-id pub-id-type="pmid">15747052</pub-id>
</element-citation></ref><ref id="B10-vaccines-13-00204"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>J.-K.</given-names></name>
<name><surname>Seiler</surname><given-names>P.</given-names></name>
<name><surname>Forrest Heather</surname><given-names>L.</given-names></name>
<name><surname>Khalenkov Alexey</surname><given-names>M.</given-names></name>
<name><surname>Franks</surname><given-names>J.</given-names></name>
<name><surname>Kumar</surname><given-names>M.</given-names></name>
<name><surname>Karesh William</surname><given-names>B.</given-names></name>
<name><surname>Gilbert</surname><given-names>M.</given-names></name>
<name><surname>Sodnomdarjaa</surname><given-names>R.</given-names></name>
<name><surname>Douangngeun</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Pathogenicity and Vaccine Efficacy of Different Clades of Asian H5N1 Avian Influenza A Viruses in Domestic Ducks</article-title><source>J. Virol.</source><year>2008</year><volume>82</volume><fpage>11374</fpage><lpage>11382</lpage><pub-id pub-id-type="doi">10.1128/JVI.01176-08</pub-id><pub-id pub-id-type="pmid">18786988</pub-id>
</element-citation></ref><ref id="B11-vaccines-13-00204"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Evseev</surname><given-names>D.</given-names></name>
<name><surname>Magor</surname><given-names>K.E.</given-names></name>
</person-group><article-title>Innate Immune Responses to Avian Influenza Viruses in Ducks and Chickens</article-title><source>Vet. Sci.</source><year>2019</year><volume>6</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci6010005</pub-id><pub-id pub-id-type="pmid">30634569</pub-id>
</element-citation></ref><ref id="B12-vaccines-13-00204"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seekings</surname><given-names>A.H.</given-names></name>
<name><surname>Warren</surname><given-names>C.J.</given-names></name>
<name><surname>Thomas</surname><given-names>S.S.</given-names></name>
<name><surname>Lean</surname><given-names>F.Z.X.</given-names></name>
<name><surname>Selden</surname><given-names>D.</given-names></name>
<name><surname>Mollett</surname><given-names>B.C.</given-names></name>
<name><surname>van Diemen</surname><given-names>P.M.</given-names></name>
<name><surname>Banyard</surname><given-names>A.C.</given-names></name>
<name><surname>Slomka</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Different Outcomes of Chicken Infection with UK-Origin H5N1-2020 and H5N8-2020 High-Pathogenicity Avian Influenza Viruses (Clade 2.3.4.4b)</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>1909</elocation-id><pub-id pub-id-type="doi">10.3390/v15091909</pub-id><pub-id pub-id-type="pmid">37766317</pub-id>
</element-citation></ref><ref id="B13-vaccines-13-00204"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kuchipudi</surname><given-names>S.V.</given-names></name>
<name><surname>Tellabati</surname><given-names>M.</given-names></name>
<name><surname>Sebastian</surname><given-names>S.</given-names></name>
<name><surname>Londt</surname><given-names>B.Z.</given-names></name>
<name><surname>Jansen</surname><given-names>C.</given-names></name>
<name><surname>Vervelde</surname><given-names>L.</given-names></name>
<name><surname>Brookes</surname><given-names>S.M.</given-names></name>
<name><surname>Brown</surname><given-names>I.H.</given-names></name>
<name><surname>Dunham</surname><given-names>S.P.</given-names></name>
<name><surname>Chang</surname><given-names>K.-C.</given-names></name>
</person-group><article-title>Highly pathogenic avian influenza virus infection in chickens but not ducks is associated with elevated host immune and pro-inflammatory responses</article-title><source>Vet. Res.</source><year>2014</year><volume>45</volume><fpage>118</fpage><pub-id pub-id-type="doi">10.1186/s13567-014-0118-3</pub-id><pub-id pub-id-type="pmid">25431115</pub-id>
</element-citation></ref><ref id="B14-vaccines-13-00204"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cornelissen</surname><given-names>J.B.W.J.</given-names></name>
<name><surname>Post</surname><given-names>J.</given-names></name>
<name><surname>Peeters</surname><given-names>B.</given-names></name>
<name><surname>Vervelde</surname><given-names>L.</given-names></name>
<name><surname>Rebel</surname><given-names>J.M.J.</given-names></name>
</person-group><article-title>Differential innate responses of chickens and ducks to low-pathogenic avian influenza</article-title><source>Avian Pathol.</source><year>2012</year><volume>41</volume><fpage>519</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1080/03079457.2012.732691</pub-id><pub-id pub-id-type="pmid">23237364</pub-id>
</element-citation></ref><ref id="B15-vaccines-13-00204"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>K.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Xu</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>T.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Xie</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Emergence of novel avian origin H7N9 viruses after introduction of H7-Re3 and rLN79 vaccine strains to China</article-title><source>Transbound. Emerg. Dis.</source><year>2022</year><volume>69</volume><fpage>213</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1111/tbed.14401</pub-id><pub-id pub-id-type="pmid">34817918</pub-id>
</element-citation></ref><ref id="B16-vaccines-13-00204"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maartens</surname><given-names>L.H.</given-names></name>
<name><surname>Frizzo da Silva</surname><given-names>L.</given-names></name>
<name><surname>Dawson</surname><given-names>S.</given-names></name>
<name><surname>Love</surname><given-names>N.</given-names></name>
<name><surname>Erasmus</surname><given-names>B.J.</given-names></name>
</person-group><article-title>The efficacy of an inactivated avian influenza H5N1 vaccine against an African strain of HPAI H5N8 (clade 2.3. 4.4 B)</article-title><source>Avian Pathol.</source><year>2023</year><volume>52</volume><fpage>176</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1080/03079457.2023.2181145</pub-id><pub-id pub-id-type="pmid">37079321</pub-id>
</element-citation></ref><ref id="B17-vaccines-13-00204"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Swayne</surname><given-names>D.E.</given-names></name>
<name><surname>Kapczynski</surname><given-names>D.R.</given-names></name>
</person-group><article-title>Vaccines and vaccination for avian influenza in poultry</article-title><source>Animal Influenza</source><publisher-name>Wiley</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2016</year><fpage>378</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1002/9781118924341.ch15</pub-id></element-citation></ref><ref id="B18-vaccines-13-00204"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>WOAH</collab>
</person-group><article-title>Avian influenza (including infection with high pathogenicity avian influenza viruses)</article-title><source>Manual of Diagnostic Tests and Vaccines for Terrestrial Animals</source><publisher-name>World Organization of Animal Health (WOAH)</publisher-name><publisher-loc>Paris, France</publisher-loc><year>2021</year><fpage>12</fpage><lpage>13</lpage></element-citation></ref><ref id="B19-vaccines-13-00204"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ali</surname><given-names>A.</given-names></name>
<name><surname>Safwat</surname><given-names>M.</given-names></name>
<name><surname>Kilany</surname><given-names>W.H.</given-names></name>
<name><surname>Nagy</surname><given-names>A.</given-names></name>
<name><surname>Shehata</surname><given-names>A.A.</given-names></name>
<name><surname>El-Abideen</surname><given-names>M.A.Z.</given-names></name>
<name><surname>Dahshan</surname><given-names>A.-H.M.</given-names></name>
<name><surname>Arafa</surname><given-names>A.-S.A.</given-names></name>
</person-group><article-title>Combined H5ND inactivated vaccine protects chickens against challenge by different clades of highly pathogenic avian influenza viruses subtype H5 and virulent Newcastle disease virus</article-title><source>Vet. World</source><year>2019</year><volume>12</volume><fpage>97</fpage><pub-id pub-id-type="doi">10.14202/vetworld.2019.97-105</pub-id><pub-id pub-id-type="pmid">30936661</pub-id>
</element-citation></ref><ref id="B20-vaccines-13-00204"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ibrahim</surname><given-names>M.</given-names></name>
<name><surname>Zakaria</surname><given-names>S.</given-names></name>
<name><surname>Bazid</surname><given-names>A.-H.I.</given-names></name>
<name><surname>Kilany</surname><given-names>W.H.</given-names></name>
<name><surname>El-Abideen</surname><given-names>M.A.Z.</given-names></name>
<name><surname>Ali</surname><given-names>A.</given-names></name>
</person-group><article-title>A single dose of inactivated oil-emulsion bivalent H5N8/H5N1 vaccine protects chickens against the lethal challenge of both highly pathogenic avian influenza viruses</article-title><source>Comp. Immunol. Microbiol. Infect. Dis.</source><year>2021</year><volume>74</volume><elocation-id>101601</elocation-id><pub-id pub-id-type="doi">10.1016/j.cimid.2020.101601</pub-id><pub-id pub-id-type="pmid">33307456</pub-id>
</element-citation></ref><ref id="B21-vaccines-13-00204"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>X.-Y.</given-names></name>
<name><surname>Chen</surname><given-names>X.-H.</given-names></name>
<name><surname>Wu</surname><given-names>J.-J.</given-names></name>
<name><surname>Bao</surname><given-names>H.-M.</given-names></name>
<name><surname>Pan</surname><given-names>S.-X.</given-names></name>
<name><surname>Liu</surname><given-names>Y.-J.</given-names></name>
<name><surname>Deng</surname><given-names>G.-H.</given-names></name>
<name><surname>Shi</surname><given-names>J.-Z.</given-names></name>
<name><surname>Chen</surname><given-names>P.-C.</given-names></name>
<name><surname>Jiang</surname><given-names>Y.-P.</given-names></name>
</person-group><article-title>Protective efficacy of an H5/H7 trivalent inactivated vaccine produced from Re-11, Re-12, and H7-Re2 strains against challenge with different H5 and H7 viruses in chickens</article-title><source>J. Integr. Agric.</source><year>2020</year><volume>19</volume><fpage>2294</fpage><lpage>2300</lpage><pub-id pub-id-type="doi">10.1016/S2095-3119(20)63301-9</pub-id></element-citation></ref><ref id="B22-vaccines-13-00204"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kilany</surname><given-names>W.H.</given-names></name>
<name><surname>Safwat</surname><given-names>M.</given-names></name>
<name><surname>Mohammed</surname><given-names>S.M.</given-names></name>
<name><surname>Salim</surname><given-names>A.</given-names></name>
<name><surname>Fasina</surname><given-names>F.O.</given-names></name>
<name><surname>Fasanmi</surname><given-names>O.G.</given-names></name>
<name><surname>Shalaby</surname><given-names>A.G.</given-names></name>
<name><surname>Dauphin</surname><given-names>G.</given-names></name>
<name><surname>Hassan</surname><given-names>M.K.</given-names></name>
<name><surname>Lubroth</surname><given-names>J.</given-names></name>
</person-group><article-title>Protective efficacy of recombinant turkey herpes virus (rHVT-H5) and inactivated H5N1 vaccines in commercial mulard ducks against the highly pathogenic avian influenza (HPAI) H5N1 clade 2.2.1 virus</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0156747</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0156747</pub-id><pub-id pub-id-type="pmid">27304069</pub-id>
</element-citation></ref><ref id="B23-vaccines-13-00204"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Swayne</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Laboratory Methods for Assessing and Licensing Influenza Vaccines for Poultry</article-title><source>Animal Influenza Virus: Methods and Protocols</source><person-group person-group-type="editor">
<name><surname>Spackman</surname><given-names>E.</given-names></name>
</person-group><publisher-name>Springer US</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2020</year><fpage>211</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-0346-8_16</pub-id></element-citation></ref><ref id="B24-vaccines-13-00204"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Swayne David</surname><given-names>E.</given-names></name>
<name><surname>Suarez David</surname><given-names>L.</given-names></name>
<name><surname>Spackman</surname><given-names>E.</given-names></name>
<name><surname>Jadhao</surname><given-names>S.</given-names></name>
<name><surname>Dauphin</surname><given-names>G.</given-names></name>
<name><surname>Kim-Torchetti</surname><given-names>M.</given-names></name>
<name><surname>McGrane</surname><given-names>J.</given-names></name>
<name><surname>Weaver</surname><given-names>J.</given-names></name>
<name><surname>Daniels</surname><given-names>P.</given-names></name>
<name><surname>Wong</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Antibody Titer Has Positive Predictive Value for Vaccine Protection against Challenge with Natural Antigenic-Drift Variants of H5N1 High-Pathogenicity Avian Influenza Viruses from Indonesia</article-title><source>J. Virol.</source><year>2015</year><volume>89</volume><fpage>3746</fpage><lpage>3762</lpage><pub-id pub-id-type="doi">10.1128/JVI.00025-15</pub-id><pub-id pub-id-type="pmid">25609805</pub-id>
</element-citation></ref><ref id="B25-vaccines-13-00204"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Spackman</surname><given-names>E.</given-names></name>
<name><surname>Killian</surname><given-names>M.L.</given-names></name>
</person-group><article-title>Avian Influenza Virus Isolation, Propagation, and Titration in Embryonated Chicken Eggs</article-title><source>Animal Influenza Virus</source><person-group person-group-type="editor">
<name><surname>Spackman</surname><given-names>E.</given-names></name>
</person-group><publisher-name>Springer New York</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2014</year><fpage>125</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-0758-8_12</pub-id></element-citation></ref><ref id="B26-vaccines-13-00204"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>EDQM</collab>
</person-group><article-title>Monograph, Sterility (2.6.1)</article-title><source>European Pharmacopoeia</source><publisher-name>EDQM</publisher-name><publisher-loc>Strasbourg, France</publisher-loc><year>2021</year><volume>Volume 10.0</volume><fpage>191</fpage><lpage>194</lpage></element-citation></ref><ref id="B27-vaccines-13-00204"><label>27.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>EDQM</collab>
</person-group><article-title>Monograph, Mycoplasmas (2.6.7)</article-title><source>European Pharmacopoeia</source><publisher-name>EDQM</publisher-name><publisher-loc>Strasbourg, France</publisher-loc><year>2021</year><volume>Volume 10.0</volume><fpage>194</fpage><lpage>199</lpage></element-citation></ref><ref id="B28-vaccines-13-00204"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kilany</surname><given-names>W.</given-names></name>
<name><surname>Dauphin</surname><given-names>G.</given-names></name>
<name><surname>Selim</surname><given-names>A.</given-names></name>
<name><surname>Tripodi</surname><given-names>A.</given-names></name>
<name><surname>Samy</surname><given-names>M.</given-names></name>
<name><surname>Sobhy</surname><given-names>H.</given-names></name>
<name><surname>VonDobschuetz</surname><given-names>S.</given-names></name>
<name><surname>Safwat</surname><given-names>M.</given-names></name>
<name><surname>Saad</surname><given-names>M.</given-names></name>
<name><surname>Erfan</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt</article-title><source>Avian Pathol.</source><year>2014</year><volume>43</volume><fpage>514</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1080/03079457.2014.966302</pub-id><pub-id pub-id-type="pmid">25245772</pub-id>
</element-citation></ref><ref id="B29-vaccines-13-00204"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>E.-K.</given-names></name>
<name><surname>Song</surname><given-names>B.-M.</given-names></name>
<name><surname>Kang</surname><given-names>H.-M.</given-names></name>
<name><surname>Woo</surname><given-names>S.-H.</given-names></name>
<name><surname>Heo</surname><given-names>G.-B.</given-names></name>
<name><surname>Jung</surname><given-names>S.C.</given-names></name>
<name><surname>Park</surname><given-names>Y.H.</given-names></name>
<name><surname>Lee</surname><given-names>Y.-J.</given-names></name>
<name><surname>Kim</surname><given-names>J.-H.</given-names></name>
</person-group><article-title>Experimental infection of SPF and Korean native chickens with highly pathogenic avian influenza virus (H5N8)</article-title><source>Poult. Sci.</source><year>2016</year><volume>95</volume><fpage>1015</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.3382/ps/pew028</pub-id><pub-id pub-id-type="pmid">26933235</pub-id>
</element-citation></ref><ref id="B30-vaccines-13-00204"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reed</surname><given-names>L.J.</given-names></name>
<name><surname>Muench</surname><given-names>H.</given-names></name>
</person-group><article-title>A simple method of estimating fifty per cent endpoints</article-title><source>Am. J. Epidemiol.</source><year>1938</year><volume>27</volume><fpage>493</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a118408</pub-id></element-citation></ref><ref id="B31-vaccines-13-00204"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Percie du Sert</surname><given-names>N.</given-names></name>
<name><surname>Hurst</surname><given-names>V.</given-names></name>
<name><surname>Ahluwalia</surname><given-names>A.</given-names></name>
<name><surname>Alam</surname><given-names>S.</given-names></name>
<name><surname>Avey</surname><given-names>M.T.</given-names></name>
<name><surname>Baker</surname><given-names>M.</given-names></name>
<name><surname>Browne</surname><given-names>W.J.</given-names></name>
<name><surname>Clark</surname><given-names>A.</given-names></name>
<name><surname>Cuthill</surname><given-names>I.C.</given-names></name>
<name><surname>Dirnagl</surname><given-names>U.</given-names></name>
</person-group><article-title>The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research</article-title><source>J. Cereb. Blood Flow Metab.</source><year>2020</year><volume>40</volume><fpage>1769</fpage><lpage>1777</lpage><pub-id pub-id-type="doi">10.1177/0271678X20943823</pub-id><pub-id pub-id-type="pmid">32663096</pub-id>
</element-citation></ref><ref id="B32-vaccines-13-00204"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duvvuri</surname><given-names>V.R.</given-names></name>
<name><surname>Duvvuri</surname><given-names>B.</given-names></name>
<name><surname>Cuff</surname><given-names>W.R.</given-names></name>
<name><surname>Wu</surname><given-names>G.E.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
</person-group><article-title>Role of Positive Selection Pressure on the Evolution of H5N1 Hemagglutinin</article-title><source>Genom. Proteom. Bioinform.</source><year>2009</year><volume>7</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/S1672-0229(08)60032-7</pub-id><pub-id pub-id-type="pmid">19591791</pub-id>
</element-citation></ref><ref id="B33-vaccines-13-00204"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yeo</surname><given-names>J.Y.</given-names></name>
<name><surname>Gan</surname><given-names>S.K.-E.</given-names></name>
</person-group><article-title>Peering into avian influenza a (H5N8) for a framework towards pandemic preparedness</article-title><source>Viruses</source><year>2021</year><volume>13</volume><elocation-id>2276</elocation-id><pub-id pub-id-type="doi">10.3390/v13112276</pub-id><pub-id pub-id-type="pmid">34835082</pub-id>
</element-citation></ref><ref id="B34-vaccines-13-00204"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naguib</surname><given-names>M.M.</given-names></name>
<name><surname>Abdelwhab</surname><given-names>E.M.</given-names></name>
<name><surname>Harder</surname><given-names>T.C.</given-names></name>
</person-group><article-title>Evolutionary features of influenza A/H5N1 virus populations in Egypt: Poultry and human health implications</article-title><source>Arch. Virol.</source><year>2016</year><volume>161</volume><fpage>1963</fpage><lpage>1967</lpage><pub-id pub-id-type="doi">10.1007/s00705-016-2849-0</pub-id><pub-id pub-id-type="pmid">27068161</pub-id>
</element-citation></ref><ref id="B35-vaccines-13-00204"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jeong</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>D.-H.</given-names></name>
<name><surname>Kwon</surname><given-names>J.-H.</given-names></name>
<name><surname>Kim</surname><given-names>Y.-J.</given-names></name>
<name><surname>Lee</surname><given-names>S.-H.</given-names></name>
<name><surname>Cho</surname><given-names>A.Y.</given-names></name>
<name><surname>Kim</surname><given-names>T.-H.</given-names></name>
<name><surname>Park</surname><given-names>J.-E.</given-names></name>
<name><surname>Lee</surname><given-names>S.-I.</given-names></name>
<name><surname>Song</surname><given-names>C.-S.</given-names></name>
</person-group><article-title>Highly pathogenic avian influenza clade 2.3. 4.4 b subtype H5N8 virus isolated from Mandarin duck in South Korea, 2020</article-title><source>Viruses</source><year>2020</year><volume>12</volume><elocation-id>1389</elocation-id><pub-id pub-id-type="doi">10.3390/v12121389</pub-id><pub-id pub-id-type="pmid">33291548</pub-id>
</element-citation></ref><ref id="B36-vaccines-13-00204"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Selim</surname><given-names>A.A.</given-names></name>
<name><surname>Erfan</surname><given-names>A.M.</given-names></name>
<name><surname>Hagag</surname><given-names>N.</given-names></name>
<name><surname>Zanaty</surname><given-names>A.</given-names></name>
<name><surname>Samir</surname><given-names>A.H.</given-names></name>
<name><surname>Samy</surname><given-names>M.</given-names></name>
<name><surname>Abdelhalim</surname><given-names>A.</given-names></name>
<name><surname>Arafa</surname><given-names>A.A.</given-names></name>
<name><surname>Soliman</surname><given-names>M.A.</given-names></name>
<name><surname>Shaheen</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Highly Pathogenic Avian Influenza Virus (H5N8) Clade 2.3.4.4 Infection in Migratory Birds, Egypt</article-title><source>Emerg. Infect. Dis.</source><year>2017</year><volume>23</volume><fpage>1048</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.3201/eid2306.162056</pub-id><pub-id pub-id-type="pmid">28518040</pub-id>
</element-citation></ref><ref id="B37-vaccines-13-00204"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sultan</surname><given-names>H.A.</given-names></name>
<name><surname>Arafa</surname><given-names>A.-E.</given-names></name>
<name><surname>Talaat</surname><given-names>S.</given-names></name>
<name><surname>Gaballa</surname><given-names>A.A.</given-names></name>
<name><surname>Kilany</surname><given-names>W.H.</given-names></name>
<name><surname>Elfeil</surname><given-names>W.K.</given-names></name>
<name><surname>Shehata</surname><given-names>A.A.</given-names></name>
<name><surname>Amarin</surname><given-names>N.</given-names></name>
</person-group><article-title>Efficacy of Clade 2.3.2 H5-Recombinant Baculovirus Vaccine in Protecting Muscovy and Pekin Ducks from Clade 2.3.4.4 H5N8 Highly Pathogenic Avian Influenza Infection</article-title><source>Avian Dis.</source><year>2019</year><volume>63</volume><fpage>219</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1637/0005-2086-63.1.219</pub-id></element-citation></ref><ref id="B38-vaccines-13-00204"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shehata</surname><given-names>A.A.</given-names></name>
<name><surname>Sedeik</surname><given-names>M.E.</given-names></name>
<name><surname>Elbestawy</surname><given-names>A.R.</given-names></name>
<name><surname>Zain El-Abideen</surname><given-names>M.A.</given-names></name>
<name><surname>Ibrahim</surname><given-names>H.H.</given-names></name>
<name><surname>Kilany</surname><given-names>W.H.</given-names></name>
<name><surname>Ali</surname><given-names>A.</given-names></name>
</person-group><article-title>Co-infections, genetic, and antigenic relatedness of avian influenza H5N8 and H5N1 viruses in domestic and wild birds in Egypt</article-title><source>Poult. Sci.</source><year>2019</year><volume>98</volume><fpage>2371</fpage><lpage>2379</lpage><pub-id pub-id-type="doi">10.3382/ps/pez011</pub-id><pub-id pub-id-type="pmid">30668795</pub-id>
</element-citation></ref><ref id="B39-vaccines-13-00204"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kandeil</surname><given-names>A.</given-names></name>
<name><surname>Hicks</surname><given-names>J.T.</given-names></name>
<name><surname>Young</surname><given-names>S.G.</given-names></name>
<name><surname>El Taweel</surname><given-names>A.N.</given-names></name>
<name><surname>Kayed</surname><given-names>A.S.</given-names></name>
<name><surname>Moatasim</surname><given-names>Y.</given-names></name>
<name><surname>Kutkat</surname><given-names>O.</given-names></name>
<name><surname>Bagato</surname><given-names>O.</given-names></name>
<name><surname>McKenzie</surname><given-names>P.P.</given-names></name>
<name><surname>Cai</surname><given-names>Z.</given-names></name>
</person-group><article-title>Active surveillance and genetic evolution of avian influenza viruses in Egypt, 2016&#x02013;2018</article-title><source>Emerg. Microbes Infect.</source><year>2019</year><volume>8</volume><fpage>1370</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.1080/22221751.2019.1663712</pub-id><pub-id pub-id-type="pmid">31526249</pub-id>
</element-citation></ref><ref id="B40-vaccines-13-00204"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cui</surname><given-names>P.</given-names></name>
<name><surname>Zeng</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Shi</surname><given-names>J.</given-names></name>
<name><surname>Zhao</surname><given-names>C.</given-names></name>
<name><surname>Qu</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Guo</surname><given-names>J.</given-names></name>
<name><surname>Gu</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Genetic and biological characteristics of the globally circulating H5N8 avian influenza viruses and the protective efficacy offered by the poultry vaccine currently used in China</article-title><source>Sci. China Life Sci.</source><year>2022</year><volume>65</volume><fpage>795</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1007/s11427-021-2025-y</pub-id><pub-id pub-id-type="pmid">34757542</pub-id>
</element-citation></ref><ref id="B41-vaccines-13-00204"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Zhuang</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Jiang</surname><given-names>W.</given-names></name>
<name><surname>Jin</surname><given-names>J.</given-names></name>
<name><surname>Peng</surname><given-names>C.</given-names></name>
<name><surname>Hou</surname><given-names>G.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Yu</surname><given-names>J.</given-names></name>
<name><surname>Yu</surname><given-names>X.</given-names></name>
<etal/>
</person-group><article-title>Control of avian influenza in China: Strategies and lessons</article-title><source>Transbound. Emerg. Dis.</source><year>2020</year><volume>67</volume><fpage>1463</fpage><lpage>1471</lpage><pub-id pub-id-type="doi">10.1111/tbed.13515</pub-id><pub-id pub-id-type="pmid">32065513</pub-id>
</element-citation></ref><ref id="B42-vaccines-13-00204"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>X.</given-names></name>
<name><surname>Tian</surname><given-names>G.</given-names></name>
<name><surname>Shi</surname><given-names>J.</given-names></name>
<name><surname>Deng</surname><given-names>G.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
</person-group><article-title>Vaccination of poultry successfully eliminated human infection with H7N9 virus in China</article-title><source>Sci. China Life Sci.</source><year>2018</year><volume>61</volume><fpage>1465</fpage><lpage>1473</lpage><pub-id pub-id-type="doi">10.1007/s11427-018-9420-1</pub-id><pub-id pub-id-type="pmid">30414008</pub-id>
</element-citation></ref><ref id="B43-vaccines-13-00204"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>EFSA Panel on Animal Health and Animal Welfare (AHAW)</collab>
<collab>European Union Reference Laboratory for Avian Influenza</collab>
<name><surname>Nielsen</surname><given-names>S.S.</given-names></name>
<name><surname>Alvarez</surname><given-names>J.</given-names></name>
<name><surname>Bicout</surname><given-names>D.J.</given-names></name>
<name><surname>Calistri</surname><given-names>P.</given-names></name>
<name><surname>Canali</surname><given-names>E.</given-names></name>
<name><surname>Drewe</surname><given-names>J.A.</given-names></name>
<name><surname>Garin-Bastuji</surname><given-names>B.</given-names></name>
<name><surname>Gonzales Rojas</surname><given-names>J.L.</given-names></name>
<etal/>
</person-group><article-title>Vaccination of poultry against highly pathogenic avian influenza&#x02013;part 1. Available vaccines and vaccination strategies</article-title><source>EFSA J.</source><year>2023</year><volume>21</volume><fpage>e08271</fpage><pub-id pub-id-type="doi">10.2903/j.efsa.2023.8271</pub-id><pub-id pub-id-type="pmid">37822713</pub-id>
</element-citation></ref><ref id="B44-vaccines-13-00204"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luczo</surname><given-names>J.M.</given-names></name>
<name><surname>Spackman</surname><given-names>E.</given-names></name>
</person-group><article-title>Epitopes in the HA and NA of H5 and H7 avian influenza viruses that are important for antigenic drift</article-title><source>FEMS Microbiol. Rev.</source><year>2024</year><volume>48</volume><elocation-id>fuae014</elocation-id><pub-id pub-id-type="doi">10.1093/femsre/fuae014</pub-id><pub-id pub-id-type="pmid">38734891</pub-id>
</element-citation></ref><ref id="B45-vaccines-13-00204"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cattoli</surname><given-names>G.</given-names></name>
<name><surname>Milani</surname><given-names>A.</given-names></name>
<name><surname>Temperton</surname><given-names>N.</given-names></name>
<name><surname>Zecchin</surname><given-names>B.</given-names></name>
<name><surname>Buratin</surname><given-names>A.</given-names></name>
<name><surname>Molesti</surname><given-names>E.</given-names></name>
<name><surname>Aly</surname><given-names>M.M.</given-names></name>
<name><surname>Arafa</surname><given-names>A.</given-names></name>
<name><surname>Capua</surname><given-names>I.</given-names></name>
</person-group><article-title>Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>8718</fpage><lpage>8724</lpage><pub-id pub-id-type="doi">10.1128/JVI.02403-10</pub-id><pub-id pub-id-type="pmid">21734057</pub-id>
</element-citation></ref><ref id="B46-vaccines-13-00204"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raymond</surname><given-names>D.D.</given-names></name>
<name><surname>Stewart</surname><given-names>S.M.</given-names></name>
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Ferdman</surname><given-names>J.</given-names></name>
<name><surname>Bajic</surname><given-names>G.</given-names></name>
<name><surname>Do</surname><given-names>K.T.</given-names></name>
<name><surname>Ernandes</surname><given-names>M.J.</given-names></name>
<name><surname>Suphaphiphat</surname><given-names>P.</given-names></name>
<name><surname>Settembre</surname><given-names>E.C.</given-names></name>
<name><surname>Dormitzer</surname><given-names>P.R.</given-names></name>
<etal/>
</person-group><article-title>Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain</article-title><source>Nat. Med.</source><year>2016</year><volume>22</volume><fpage>1465</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1038/nm.4223</pub-id><pub-id pub-id-type="pmid">27820604</pub-id>
</element-citation></ref><ref id="B47-vaccines-13-00204"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salaheldin</surname><given-names>A.H.</given-names></name>
<name><surname>Elbestawy</surname><given-names>A.R.</given-names></name>
<name><surname>Abdelkader</surname><given-names>A.M.</given-names></name>
<name><surname>Sultan</surname><given-names>H.A.</given-names></name>
<name><surname>Ibrahim</surname><given-names>A.A.</given-names></name>
<name><surname>Abd El-Hamid</surname><given-names>H.S.</given-names></name>
<name><surname>Abdelwhab</surname><given-names>E.M.</given-names></name>
</person-group><article-title>Isolation of genetically diverse H5N8 avian influenza viruses in poultry in Egypt, 2019&#x02013;2021</article-title><source>Viruses</source><year>2022</year><volume>14</volume><elocation-id>1431</elocation-id><pub-id pub-id-type="doi">10.3390/v14071431</pub-id><pub-id pub-id-type="pmid">35891409</pub-id>
</element-citation></ref><ref id="B48-vaccines-13-00204"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>Y.</given-names></name>
<name><surname>Ibrahim</surname><given-names>M.S.</given-names></name>
<name><surname>Ellakany</surname><given-names>H.F.</given-names></name>
<name><surname>Kawashita</surname><given-names>N.</given-names></name>
<name><surname>Daidoji</surname><given-names>T.</given-names></name>
<name><surname>Takagi</surname><given-names>T.</given-names></name>
<name><surname>Yasunaga</surname><given-names>T.</given-names></name>
<name><surname>Nakaya</surname><given-names>T.</given-names></name>
<name><surname>Ikuta</surname><given-names>K.</given-names></name>
</person-group><article-title>Antigenic analysis of highly pathogenic avian influenza virus H5N1 sublineages co-circulating in Egypt</article-title><source>J. Gen. Virol.</source><year>2012</year><volume>93</volume><fpage>2215</fpage><lpage>2226</lpage><pub-id pub-id-type="doi">10.1099/vir.0.044032-0</pub-id><pub-id pub-id-type="pmid">22791605</pub-id>
</element-citation></ref><ref id="B49-vaccines-13-00204"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mo</surname><given-names>J.</given-names></name>
<name><surname>Spackman</surname><given-names>E.</given-names></name>
<name><surname>Swayne</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Prediction of highly pathogenic avian influenza vaccine efficacy in chickens by comparison of in vitro and in vivo data: A meta-analysis and systematic review</article-title><source>Vaccine</source><year>2023</year><volume>41</volume><fpage>5507</fpage><lpage>5517</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2023.07.076</pub-id><pub-id pub-id-type="pmid">37537093</pub-id>
</element-citation></ref><ref id="B50-vaccines-13-00204"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Spackman</surname><given-names>E.</given-names></name>
<name><surname>Suarez</surname><given-names>D.L.</given-names></name>
<name><surname>Lee</surname><given-names>C.-W.</given-names></name>
<name><surname>Pantin-Jackwood</surname><given-names>M.J.</given-names></name>
<name><surname>Lee</surname><given-names>S.A.</given-names></name>
<name><surname>Youk</surname><given-names>S.</given-names></name>
<name><surname>Ibrahim</surname><given-names>S.</given-names></name>
</person-group><article-title>Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens</article-title><source>Vaccine</source><year>2023</year><volume>41</volume><fpage>7369</fpage><lpage>7376</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2023.10.070</pub-id><pub-id pub-id-type="pmid">37932132</pub-id>
</element-citation></ref><ref id="B51-vaccines-13-00204"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kumar</surname><given-names>M.</given-names></name>
<name><surname>Chu</surname><given-names>H.-J.</given-names></name>
<name><surname>Rodenberg</surname><given-names>J.</given-names></name>
<name><surname>Krauss</surname><given-names>S.</given-names></name>
<name><surname>Webster</surname><given-names>R.G.</given-names></name>
</person-group><article-title>Association of Serologic and Protective Responses of Avian Influenza Vaccines in Chickens</article-title><source>Avian Dis.</source><year>2007</year><volume>51</volume><fpage>481</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1637/7605-041706R1.1</pub-id><pub-id pub-id-type="pmid">17494614</pub-id>
</element-citation></ref><ref id="B52-vaccines-13-00204"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>D.-H.</given-names></name>
<name><surname>Kwon</surname><given-names>J.-H.</given-names></name>
<name><surname>Noh</surname><given-names>J.-Y.</given-names></name>
<name><surname>Park</surname><given-names>J.-K.</given-names></name>
<name><surname>Yuk</surname><given-names>S.-S.</given-names></name>
<name><surname>Erdene-Ochir</surname><given-names>T.-O.</given-names></name>
<name><surname>Lee</surname><given-names>J.-B.</given-names></name>
<name><surname>Park</surname><given-names>S.-Y.</given-names></name>
<name><surname>Choi</surname><given-names>I.-S.</given-names></name>
<name><surname>Lee</surname><given-names>S.-W.</given-names></name>
<etal/>
</person-group><article-title>Pathogenicity of the Korean H5N8 highly pathogenic avian influenza virus in commercial domestic poultry species</article-title><source>Avian Pathol.</source><year>2016</year><volume>45</volume><fpage>208</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1080/03079457.2016.1142502</pub-id><pub-id pub-id-type="pmid">26814367</pub-id>
</element-citation></ref><ref id="B53-vaccines-13-00204"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beerens</surname><given-names>N.</given-names></name>
<name><surname>Germeraad</surname><given-names>E.A.</given-names></name>
<name><surname>Venema</surname><given-names>S.</given-names></name>
<name><surname>Verheij</surname><given-names>E.</given-names></name>
<name><surname>Pritz-Verschuren</surname><given-names>S.B.E.</given-names></name>
<name><surname>Gonzales</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Comparative pathogenicity and environmental transmission of recent highly pathogenic avian influenza H5 viruses</article-title><source>Emerg. Microbes Infect.</source><year>2021</year><volume>10</volume><fpage>97</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1080/22221751.2020.1868274</pub-id><pub-id pub-id-type="pmid">33350337</pub-id>
</element-citation></ref><ref id="B54-vaccines-13-00204"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pasick</surname><given-names>J.</given-names></name>
</person-group><article-title>Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication</article-title><source>Anim. Health Res. Rev.</source><year>2007</year><volume>5</volume><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1079/AHR200479</pub-id></element-citation></ref><ref id="B55-vaccines-13-00204"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>H.</given-names></name>
<name><surname>Zhu</surname><given-names>S.</given-names></name>
<name><surname>Govinden</surname><given-names>R.</given-names></name>
<name><surname>Chenia</surname><given-names>H.Y.</given-names></name>
</person-group><article-title>Multiple Vaccines and Strategies for Pandemic Preparedness of Avian Influenza Virus</article-title><source>Viruses</source><year>2023</year><volume>15</volume><elocation-id>1694</elocation-id><pub-id pub-id-type="doi">10.3390/v15081694</pub-id><pub-id pub-id-type="pmid">37632036</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vaccines-13-00204-f001"><label>Figure 1</label><caption><p>Scheme of the experimental design. DOA: day of age, GA: Group A, GB: Group B, VC: vaccinated challenged, UC: unvaccinated challenged, NC: negative control, CO: chicken origin, DO: duck origin, DPC: days post-challenge.</p></caption><graphic xlink:href="vaccines-13-00204-g001" position="float"/></fig><fig position="float" id="vaccines-13-00204-f002"><label>Figure 2</label><caption><p>Profile of weekly log<sub>2</sub> HI antibody responses of chickens vaccinated with MEFULVAC&#x02122; H5 Plus 8 against diagnostic antigens resembling AIV H5N1 subtype clades 2.2.1.1, 2.2.1.2, and AIV H5N8 subtype clade 2.3.4.4b. Chickens were vaccinated at 2 weeks of age (2 WOA)<bold>.</bold> Data are presented as the mean &#x000b1; standard deviation (SD).</p></caption><graphic xlink:href="vaccines-13-00204-g002" position="float"/></fig><fig position="float" id="vaccines-13-00204-f003"><label>Figure 3</label><caption><p>Survival curves of unvaccinated and vaccinated SPF chickens after challenge with 0.1 mL of 10<sup>6.0</sup> EID<sub>50</sub> of HPAI H5N1 subtype clade 2.2.1.2 (<bold>A</bold>), HPAI H5N8 subtype clade 2.3.4.4b virus (chicken origin) (<bold>B</bold>), and HPAI H5N8 subtype clade 2.3.4.4b virus (duck origin) (<bold>C</bold>). NC: negative control, VC: vaccinated challenged, UC: unvaccinated challenged. Chickens were challenged at 6 weeks of age (6 WOA).</p></caption><graphic xlink:href="vaccines-13-00204-g003" position="float"/></fig><table-wrap position="float" id="vaccines-13-00204-t001"><object-id pub-id-type="pii">vaccines-13-00204-t001_Table 1</object-id><label>Table 1</label><caption><p>Experimental design of vaccination trial and post-vaccination challenge study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Group(s) <sup>i</sup></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Vaccination, 2 WOA</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Challenge, 6 WOA</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dose/Route</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment <sup>ii</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dose/Route</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">GA (<italic toggle="yes">n</italic> = 45)</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Vaccine</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.5 mL/IM inj.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GA1 (<italic toggle="yes">n</italic> = 15): HPAI H5N1 clade 2.2.1.2 (VC)</td><td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">100 &#x000b5;L, 6.0 log<sub>10</sub> EID<sub>50</sub>/Oculonasal</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GA2 (<italic toggle="yes">n</italic> = 15): HPAI H5N8 clade 2.3.4.4b, CO (VC)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GA3 (<italic toggle="yes">n</italic> = 15): HPAI H5N8 clade 2.3.4.4b, DO (VC)</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">GB (<italic toggle="yes">n</italic> = 60)</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Saline</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.5 mL/IM inj.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB1 (<italic toggle="yes">n</italic> = 15): HPAI H5N1 clade 2.2.1.2 (UC)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB2 (<italic toggle="yes">n</italic> = 15): HPAI H5N8 clade 2.3.4.4b, CO (UC)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB3 (<italic toggle="yes">n</italic> = 15): HPAI H5N8 Clade 2.3.4.4b, DO (UC)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB4 (<italic toggle="yes">n</italic> = 15): NC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 &#x000b5;L/oculonasal</td></tr></tbody></table><table-wrap-foot><fn><p><sup>i</sup> Abbreviations: WOA: weeks of age, IM inj.: intramuscular injection, VC: vaccinated challenged, UC, unvaccinated challenged, NC: negative control, CO: chicken origin, DO: duck origin. <sup>ii</sup> Experimental GA and GB were divided into equal subgroups (GA1, GA2, GA3, GB1, GB2, GB3, and GB4) at 6 WOA.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vaccines-13-00204-t002"><object-id pub-id-type="pii">vaccines-13-00204-t002_Table 2</object-id><label>Table 2</label><caption><p>Amino acid identity of MEFLUVAC&#x02122; H5 Plus 8 vaccine reassortant seed viruses compared to Egyptian HPAI H5N1 and H5N8 subtypes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin; border-bottom:solid thin" rowspan="1" colspan="1">S</th><th align="center" valign="middle" style="border-top:solid thin; border-bottom:solid thin" rowspan="1" colspan="1">Vaccine Strains</th><th align="center" valign="middle" style="border-top:solid thin; border-bottom:solid thin" rowspan="1" colspan="1">Accession No.</th><th align="center" valign="middle" style="border-top:solid thin; border-bottom:solid thin" rowspan="1" colspan="1">HPAI H5N8 Clade 2.3.4.4b<break/>(<italic toggle="yes">n</italic> = 171) <sup>iii</sup></th><th align="center" valign="middle" style="border-top:solid thin; border-bottom:solid thin" rowspan="1" colspan="1">HPAI H5N1 Clade 2.2.1.2<break/>(<italic toggle="yes">n</italic> = 298)</th><th align="center" valign="middle" style="border-top:solid thin; border-bottom:solid thin" rowspan="1" colspan="1">HPAI H5N1 Clade 2.2.1.1 (<italic toggle="yes">n</italic> = 77)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> H5N8 2.3.4.4b; rgA/CK <sup>iv</sup>/ME-2018/H5N8 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MW193074.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.0&#x02013;100%&#x000a0;<sup>v</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.7&#x02013;91.7%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.9&#x02013;91.2%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H5N1 2.2.1.2; A/CK/Egypt/RG-173 CAL/2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MG192005.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90.3&#x02013;92.4%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94.6&#x02013;98.6%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">92.1&#x02013;95.3%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H5N1 2.2.1.1; RgA/CK/Egypt/ME1010/2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MH558951.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.9&#x02013;91.0%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89.4&#x02013;92.9%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.2&#x02013;96.3%</td></tr></tbody></table><table-wrap-foot><fn><p><sup>iii</sup> Number of retrieved complete HA protein sequences from GISAID EpiFlu&#x02122; platform and aligned using MUSCLE. <sup>iv</sup> Chicken. <sup>v</sup> (min&#x02013;max).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vaccines-13-00204-t003"><object-id pub-id-type="pii">vaccines-13-00204-t003_Table 3</object-id><label>Table 3</label><caption><p>Characteristic amino acid substitutions in antigenic site (AS), receptor binding site (RBS), and N-glycosylation site (GS) of the haemagglutinin protein of the vaccine and challenge strains.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Amino Acid Residue No.</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">HPAI Challenge Strains</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Reassortant LPAI Vaccine Strains</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Predicted HA Domain or Structure [<xref rid="B32-vaccines-13-00204" ref-type="bibr">32</xref>]</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EPI_ISL_174424 H5N1 2.2.1.2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ON024718.1 H5N8 2.3.4.4b<break/>CO <sup>vi</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ON024724.1 H5N8 2.3.4.4b<break/>DO <sup>vii</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MW193074.1 H5N8 2.3.4.4b</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MG192005.1<break/>H5N1 2.2.1.2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MH558951.1 H5N1 2.2.1.1</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> 43 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">. <sup>viii</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eE <sup>ix</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AS</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eE</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eE</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eE</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eE</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">115</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Q</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AS<break/>eA <sup>x</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">123</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">124</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AS<break/>eA</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">127</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eA</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">129</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">- <sup>xi</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RBS/eA</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">133</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">140</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AS/eB <sup>xii</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">141</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AS/eB</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">144</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Y</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eB</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">151</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eD <sup>xiii</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">155</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eD</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">156</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eD</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">162</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">165</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GS</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">169</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Q</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">174</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eB</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">181</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eB</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">183</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">184</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">185</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AS eD</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">189</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AS/RBS</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">190</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RBS</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">192</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Q</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eD</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">195</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">218</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Q</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Q</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Q</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RBS</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">223</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">226</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">eD</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">227</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">235</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">238</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">240</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">252</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Y</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Y</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Y</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">268</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">269</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">270</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">272</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">275</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">282</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">310</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">K</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn><p><sup>vi</sup> Chicken origin. <sup>vii</sup> Duck origin. <sup>viii</sup> Residues that are identical to CK/Eg/1575S/2015, ISL_174424, H5N1 2.2.1.2. The studied receptor binding and antigenic sites are previously reported by (Duvvuri, et al., 2009 [<xref rid="B32-vaccines-13-00204" ref-type="bibr">32</xref>]). <sup>ix</sup> Epitope E. <sup>x</sup> Epitope A. <sup>xi</sup> Not found, deletion. <sup>xii</sup> Epitope B. <sup>xiii</sup> Epitope D.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vaccines-13-00204-t004"><object-id pub-id-type="pii">vaccines-13-00204-t004_Table 4</object-id><label>Table 4</label><caption><p>Post-vaccination HI mean antibody titers (log<sub>2</sub>) and seroconversion rates in SPF chickens vaccinated with MEFLUVAC&#x02122; H5 Plus 8 against AIV H5N1 subtype clades 2.2.1.1 and 2.2.1.2 and H5N8 subtype clade 2.3.4.4b diagnostic antigens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Group(s) <sup>xiv</sup></th><th rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Antigen</th><th colspan="8" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Weeks Post-Vaccination (WPV)</th></tr><tr><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">1</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">2</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">3</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">4</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Titer <sup>xv</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">% <sup>xvi</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Titer</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Titer</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Titer</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> GA </td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">AIV H5N1, Clade 2.2.1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.6 &#x000b1; 1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.3 &#x000b1; 1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.8 &#x000b1; 1.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.4 &#x000b1; 1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd <sup>xvii</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A <sup>xviii</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GA</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">AIV H5N1, Clade 2.2.1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.1 &#x000b1; 0.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.0 &#x000b1; 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.0 &#x000b1; 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.0 &#x000b1; 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GA</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">AIV H5N8, Clade 2.3.4.4b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.0 &#x000b1; 0.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.5 &#x000b1; 0.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.5 &#x000b1; 0.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.8 &#x000b1; 0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nd</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr></tbody></table><table-wrap-foot><fn><p><sup>xiv</sup> Group A (n = 45): vaccinated, Group B (n = 60): unvaccinated. <sup>xv</sup> The mean hemagglutination inhibition titer &#x000b1; SD is expressed as log<sub>2</sub> HIU. <sup>xvi</sup>&#x000a0;
<inline-formula><mml:math id="mm2" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mo>%</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi>N</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>d</mml:mi><mml:mi>s</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>H</mml:mi><mml:mi>I</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo>(</mml:mo><mml:mo>&#x02265;</mml:mo><mml:mn>3.0</mml:mn><mml:mo>&#x000a0;</mml:mo><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>b</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>d</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>
<sup>xvii</sup> Not detected. <sup>xviii</sup> Not applicable.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vaccines-13-00204-t005"><object-id pub-id-type="pii">vaccines-13-00204-t005_Table 5</object-id><label>Table 5</label><caption><p>Virus shedding titers (log<sub>10</sub> EID<sub>50</sub>/mL) on the 2nd, 4th, 7th, and 10th day post challenge (DPC).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Group(s) <sup>xix</sup> (<italic toggle="yes">n</italic> = 15 for Each Group)</th><th colspan="8" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Days Post Challenge (DPC)</th></tr><tr><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">2</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">4</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">7</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">10</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Titer <sup>xx</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positivity <sup>xxi</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Titer</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positivity</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Titer</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positivity</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Titer</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positivity</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GA1: VC-2.2.1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.2 &#x000b1; 0.00 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6/15 (40%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5 &#x000b1; 0.36 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3/15 (20%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GA2: VC-2.3.4.4b, CO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.5 &#x000b1; 0.26 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5/15 (33%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.6 &#x000b1; 0.29 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3/15 (20%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GA3: VC-2.3.4.4b, DO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5 &#x000b1; 0.30 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4/15 (27%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.4 &#x000b1; 0.00 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2/15 (13%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB1: UC-2.2.1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.6 &#x000b1; 0.25 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12/12 (100%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A <sup>xxii</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB2: UC-2.3.4.4b, CO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.5 &#x000b1; 0.21 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10/10 (100%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB3: UC-2.3.4.4b, DO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.5 &#x000b1; 0.25 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15/15 (100%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.0 &#x000b1; 0.27 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9/9 (100%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GB4: NC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0 &#x000b1; 0.00 <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0/15<break/>(0%)</td></tr></tbody></table><table-wrap-foot><fn><p><sup>xix</sup> VC: vaccinated challenged, UC: unvaccinated challenged, NC: negative control, CO: chicken origin, DO: duck origin. <sup>xx</sup> The mean shedding titer &#x000b1; SD is expressed as log<sub>10</sub> EID<sub>50</sub>/mL. Virus titers in the same column followed by different small letters are statistically different (<italic toggle="yes">p</italic> &#x002c2; 0.05). <sup>xxi</sup> Positivity %: percentage of active virus shedder birds out of the total number of the tested samples. <sup>xxii</sup> Not applicable.</p></fn></table-wrap-foot></table-wrap></floats-group></article>